WILLIAM J. LINK PHD - 16 Jun 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARS	Stock Option (right to buy)	Award	$0	+7,000		$0.000000	7,000	16 Jun 2022	Common Stock	7,000	$12.89	Direct	F1
transaction	TARS	Restricted Stock Units	Award	$0	+2,000		$0.000000	2,000	16 Jun 2022	Common Stock	2,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F3	RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.